All Topics

Brazil's health regulator ANVISA has published four public consultations that fundamentally reshape the regulatory framework for medical device reprocessing, moving from a prohibited-products list to a risk-based validation system. The proposals shift responsibility for reuse decisions to healthcare facilities while imposing new labeling requirements and authorization obligations on manufacturers, importers, and processing companies.

Juliane Mendonça, head of Corporate Criminal Law at KLA, contributes a chapter examining the criminal liability of intermediaries in bribery cases involving public officials. The work addresses a controversial question in Brazilian jurisprudence: should an intermediary who facilitates the receipt of undue advantages by public officials be charged with active or passive corruption?

A partir de 13 de outubro de 2026, o Conselho Monetário Nacional estabeleceu novas restrições significativas para FIDCs e FIC-FIDCs na aquisição de créditos decorrentes de ações judiciais e procedimentos arbitrais. A medida exige que créditos possuam liquidez, certeza e exigibilidade em caráter definitivo, incluindo trânsito em julgado, impactando profundamente o mercado de special situations e legal claims no Brasil.